• Tirzepatide

    Tirzepatide

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Tirzepatide Type 2 diabetes, lose weight Eli Lilly  Jan.05,2036
  • Thalidomide

    Thalidomide

    API’s Name Indication Specification US DMF  EU DMF  CEP
    Thalidomide Oncology drug USP/EP      
  • Ticagrelor

    Ticagrelor

    API’s Name Indication Specification US DMF  EU DMF  CEP
    Ticagrelor Anticoagulant In-House 28984  
  • Tofacitnib Citrate

    Tofacitnib Citrate

    API’s Name Indication Specification US DMF  EU DMF  CEP
    Tofacitnib Citrate Rheumatoid arthritis In-House